Nomura Holdings’s AstraZeneca AZN Stock Holding History

Nomura Holdings’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-72,200	Closed	-$11.3M	–	2176
2024 Q3	$11.3M	Buy	+72,200	New	+$11.7M	0.03%	404
2024 Q1	–	Sell	-40,950	Closed	-$5.52M	–	1628
2023 Q4	$5.52M	Buy	+40,950	New	+$5.32M	0.01%	630
2023 Q2	–	Sell	-56,275	Closed	-$7.81M	–	1364
2023 Q1	$7.81M	Buy	+56,275	New	+$7.57M	0.02%	435
2022 Q4	–	Sell	-24,275	Closed	-$2.66M	–	1504
2022 Q3	$2.66M	Buy	+24,275	New	+$3.08M	0.01%	738
2015 Q1	–	Sell	-733,400	Closed	-$51.7M	–	1757
2014 Q4	$51.7M	Sell	733,400 -553,100	-43%	-$39.6M	0.14%	99
2014 Q3	$92M	Buy	1,286,500 +626,500	+95%	+$45.9M	0.25%	72
2014 Q2	$49M	Buy	660,000 +410,000	+164%	+$29.6M	0.01%	159
2014 Q1	$16.2M	Buy	+250,000	New	+$16.1M	0.01%	332

Other funds holding AZN

Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

VAM

Vanguard Asset Management London, Ec4n 8af $117B AUM

Nomura Holdings's AZN Position: Q1 2026 in Review

Nomura Holdings sold out of AstraZeneca (AZN) in Q1 2026, closing a stake of 54,898 shares — an estimated $10.1M sold.

Nomura Holdings first reported a position in AZN in Q3 2013 and held it in 21 quarters. The position peaked at $11.4M in Q1 2025. 1,379 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

Nomura Holdings reported no remaining AstraZeneca position as of Q1 2026 after selling out during the quarter.
Nomura Holdings sold 54,898 AstraZeneca shares in Q1 2026, an estimated $10.1M.
Nomura Holdings first reported a position in AstraZeneca in Q3 2013 and held it in 21 quarters.
Nomura Holdings's AstraZeneca position peaked at $11.4M in Q1 2025.
1,379 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Nomura Holdings's 13F filing for Q1 2026, filed 15 May 2026.